Available strengths include 10mg, 12mg, 15mg, 20mg, 24mg, 30mg, and 40mg, providing flexibility for both small-scale and long-term research projects
The psychological burden of weight struggles touches millions of families, affecting productivity, relationships, and overall life satisfaction
Gastrointestinal side effects represent the most common adverse events associated with GLP-1 therapy, affecting 30-50% of patients to varying degrees
Beyond gastrointestinal effects, clinical data and class-level evidence from licensed incretin agents (semaglutide, tirzepatide) have flagged concerns regarding: Heart rate elevation: Increases in resting heart rate are a recognised class effect of GLP-1 receptor agonists, documented in the SmPCs for semaglutide (Wegovy) and tirzepatide (Mounjaro)
One miscalculation at the 8mg dose and you have either underdosed an entire week or wasted half a vial in a single draw
H., & Blher, M